Genexis Group presents Q3 2024 financial report

Genexis Group’s net sales Q3 2024 were EUR 16.2 million, EUR 0.9 million higher than Q3
2023. Order intake was EUR 14.8 million, EUR 4.7 million above Q3 2023.

Genexis Group’s net sales Q3 2024 were EUR 16.2 million, EUR 0.9 million higher than Q3
2023. Order intake was EUR 14.8 million, EUR 4.7 million above Q3 2023.

The consolidated adjusted EBITDA for Q3 was EUR 2.8 million (EUR 2.2 million Q3 2023), and
the operaUng cash flow aWer investment acUviUes in Q3 2024 was EUR -0.3 million.
 

“The market was stable in our core regions, however sUll showing limited signs of recovery in
the short term. Our volumes and revenue increased year-over year, and gross margins were
good, partly due to good soWware sales and partly due to posiUve geographic mix effect”
says Genexis Group CEO Gerlas van den Hoven. “Our geographical expansion in the UK and
North America conUnues and feedback on our offerings is very posiUve. During the quarter
we signed one new customer in the USA, and we expect several engagements converUng to
tangible business in 2025”.

During the quarter Genexis was awarded a presUgious Gold Medal from Eco Vadis for the
second consecuUve year. The achievement, where the company moved to top 2% in the
industry from top 4% 2023, underlines Genexis’ dedicaUon to sustainability and being a
frontrunner in our industry.

You find the complete report on the Genexis website

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OR TO U.S. PERSONS OR IN OR INTO ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL.